Abram K, Silm H, Oona M. Prevalence of Rosacea in an Estonian Working Population Using a Standard Classification. Acta Dermato Venereologica. 2010; 90:(3)269-273

Rosacea. Primary Care Dermatology Society. 2018. (accessed 18 January 2019)

Dahl MV. A treatment strategy for rosacea. In: Pathogenesis and treatment of acne and rosacea.Springer, Berlin: Springer; 2014

Del Rosso JQ. Management of cutaneous rosacea: emphasis on new medical therapies. Expert Opinion on Pharmacotherapy. 2014; 15:(14)2029-2038

Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Patients with Rosacea Have Increased Risk of Depression and Anxiety Disorders: A Danish Nationwide Cohort Study. Dermatology. 2016; 232:(2)208-213

Elewski BE, Fleischer AB, Pariser DM. A Comparison of 15% Azelaic Acid Gel and 0.75% Metronidazole Gel in the Topical Treatment of Papulopustular Rosacea: Results of a Randomized Trial. Archives of Dermatology. 2003; 139:(11)

Gether L, Overgaard LK, Egeberg A, Thyssen JP. Incidence and prevalence of rosacea: a systematic review and meta-analysis. British Journal of Dermatology. 2018;

Gonzalez-Hinojosa D, Jaime-Villalonga A, Aguilar-Montes G, Lammoglia-Ordiales L. Demodex and rosacea: Is there a relationship?. Indian Journal of Ophthalmology. 2018; 66:(1)

Han SH, Young SJ, Kong SH, Kim JH, Suh HS, Choi YS. P006: a case of erythematotelangiectatic rosacea successfully treated with carvedilol. 2016; 68:(1)298-299

Handler MZ, Bloom BS, Goldberg DJ. IPL vs PDL in treatment of facial erythema: a split-face study. Journal of Cosmetic Dermatology. 2017; 16:(4)450-453

Jafferany M, Franca K. Psychodermatology: Basics Concepts. Acta Dermato Venereologica. 2014;

Johnston SA, Krasuska M, Millings A Experiences of rosacea and its treatment: an interpretative phenomenological analysis. British Journal of Dermatology. 2018; 178:(1)154-160

Kim S-J, Lee Y, Seo Y-J Comparative Efficacy of Radiofrequency and Pulsed Dye Laser in the Treatment of Rosacea: Dermatologic Surgery. 2017; 43:(2)204-209

Machalińska A, Zakrzewska A, Markowska A Morphological and Functional Evaluation of Meibomian Gland Dysfunction in Rosacea Patients. Current Eye Research. 2016; 41:(8)1029-1034

McGregor SP, Alinia H, Snyder A A Review of the Current Modalities for the Treatment of Papulopustular Rosacea. Dermatologic Clinics. 2018; 36:(2)135-150

Moustafa F, Hopkinson D, Huang KE, Feldman S. Prevalence of Rosacea in Community Settings. Journal of Cutaneous Medicine and Surgery. 2015; 19:(2)149-152

Muto Y, Wang Z, Vanderberghe M Mast Cells Are Key Mediators of Cathelicidin-Initiated Skin Inflammation in Rosacea. Journal of Investigative Dermatology. 2014; 134:(11)2728-2736

National Institute for Health and Care Excellence. Facial erythema of rosacea: brimonidine tartrate gel. Evidence summary [ESNM 43]. 2014. (accessed 18 January 2019)

Saleem MD, Wilkin JK. Evaluating and Optimizing the Diagnosis of Erythematotelangiectatic Rosacea. Dermatologic Clinics. 2018; 36:(2)127-134

Stein L, Kircik L, Fowler J Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies. J Drugs Dermatol. 2014; 13:(3)316-323

Steinhoff M, Schmelz M, Schauber J. Facial Erythema of Rosacea – Aetiology, Different Pathophysiologies and Treatment Options. Acta Dermato Venereologica. 2016; 96:(5)579-586

Tan J, Schöfer H, Araviiskaia E Prevalence of rosacea in the general population of Germany and Russia - The RISE study. Journal of the European Academy of Dermatology and Venereology. 2016; 30:(3)428-434

Thompson AR. Treatment challenges: getting psychodermatology into the clinic. Dermatological Nursing. 2014; 13:(4)26-31

van Zuuren EJ, Fedorowicz Z, Carter B Interventions for rosacea. Cochrane Skin Group, ed. Cochrane Database of Systematic Reviews. 2015;

Wilkin J, Dahl M, Detmar M Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002; 46:(4)584-587

Rosacea: approaches to a complex and chronic skin condition

02 February 2019
Volume 8 · Issue 1


Rosacea is a chronic condition of the skin, which is specifically localised to the face. There are several different classifications of rosacea, and it can be a difficult condition to treat, often going misdiagnosed or mistreated. Rosacea can also have a significant psychological impact on the patient's life, and it is important that this impact is considered by the practitioner when determining a treatment plan. This article will explore the different classifications of rosacea and the various options available in treating the condition.

Rosacea is a chronic condition of the skin. There are several different classifications, which makes rosacea a difficult condition to treat. One common symptom of Rosacea is facial flushing, and patients often report that they find this to be one of the most distressing features of the condition. Flushing of the skin is caused by a dysfunction of the neurovascular system, which causes involuntary vasodilatory flushing, generalised redness and erythema, with associated pustules and papules (Wilkin et al, 2002). In addition to this, Steinhoff et al (2016) suggested that there are elements of the immune system that are also involved in the disease process.

Colonisation of the skin is suggested to be another trigger factor in relation to rosacea, with dermidex folliculorum and dermidex brevis being two of the organisms responsible for this. Helicobacter pylori is also suggested to play a role in the disease pathogenesis (Gether et al, 2018).

Register now to continue reading

Thank you for visiting Journal of Aesthetic Nurses and reading some of our peer-reviewed resources for aesthetic nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month